Skip to main content
. 2019 Apr 28;25(16):1950–1963. doi: 10.3748/wjg.v25.i16.1950

Figure 2.

Figure 2

Phenotypes of NK cells in different clinical phases. A: Frequency of CD56bright and CD56dim NK cells expressing the activating receptor NKp46; B: Frequency of CD56bright and CD56dim NK cells expressing the activating receptor NKp44; C: Frequency of CD56bright and CD56dim NK cells expressing the activating receptor NKp30; D: Frequency of CD56bright and CD56dim NK cells expressing the inhibitory receptor NKG2A; E: Frequency of CD56bright and CD56dim NK cells expressing the activating receptor NKG2D; F: Frequency of CD56bright and CD56dim NK cells expressing the activating marker CD69. NK: Natural killer; HD: Healthy honors; IT: Immune tolerant; IA: Immune active; IC: Inactive carrier; ENEG: Hepatitis B envelope antigen-negative hepatitis. All data are presented as mean ± SD, aP < 0.05, bP < 0.01, cP < 0.001.